Myocardial Infarct
11
3
4
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
9.1%
1 terminated out of 11 trials
83.3%
-3.2% vs benchmark
18%
2 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (11)
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
STunning in Acute Myocardial Infarction - BAS
Heart Attack Blood Oxygen Therapy Trial
The Effect of Physical Activity Level Evaluated by Wrist-wearable Devices on Cardiovascular Disease Risk and Other Outcomes in Peritoneal Dialysis Patients
CARdioprotection in Myocardial Infarction
IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing CABG
Observational Study of the Remodelling Process Following Myocardial Infarct
Safety and Tolerability of RNS60 Given by IV to Healthy Subjects
Impact of Tight Glycaemic Control in Acute Myocardial Infarction
Ilomedin Treatment for Patients Having Undergone Primary Percutaneous Coronary Intervention (PCI)
Efficacy Study of Intramuscular or Intracoronary Injection of Autologous Bone Marrow Cells to Treat Scarred Myocardium